رجوع
نطاق اليوم
KWD 17.94
KWD 18.98
نطاق 52 أسبوعًا
KWD 12.88
KWD 19.63
حجم التداول
982,633
متوسط 50 يوم / 200 يوم
KWD 14.26
/
KWD 14.26
الإغلاق السابق
KWD 18.40
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.8 | 0.4 |
| P/B | 5.4 | 2.9 |
| ROE % | -64.1 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 31.200
+72.4%
Low: KWD 25.000
High: KWD 37.000
ربحية السهم المستقبلية
-KWD 1.944
الإيرادات المقدّرة
0
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 2.927
KWD 2.927 – KWD 2.927
|
820 M | 4 |
| FY2029 |
KWD 0.993
KWD 0.993 – KWD 0.993
|
490 M | 4 |
| FY2028 |
-KWD 0.541
-KWD 1.893 – KWD 2.952
|
220 M | 10 |
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -131.56M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-64.06%
ROIC-37.53%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio6.29
Interest Coverage-30.34
التقييم
P/E Ratio
-9.82
P/B Ratio5.43
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -183.79M |
| ROE | -64.06% | ROA | -41.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131.56M |
| ROIC | -37.53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.29 |
| Interest Coverage | -30.34 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.82 | P/B Ratio | 5.43 |
| P/S Ratio | N/A | PEG Ratio | -0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.80B | Enterprise Value | 1.55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -183.79M | -108.68M | -95.73M | -56.80M | -93.04M |
| EPS (Diluted) | -2.06 | -0.15 | -2.44 | -1.53 | -3.40 |
| Gross Profit | 0.0 | -527,000.0 | -3.16M | 0.0 | 0.0 |
| Operating Income | -166.31M | -103.92M | -93.87M | -66.33M | -93.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 440.10M | 302.15M | 124.54M | 169.99M | 164.00M |
| Total Liabilities | 107.77M | 60.70M | 46.41M | 19.08M | 12.34M |
| Shareholders' Equity | 332.33M | 241.45M | 78.13M | 150.92M | 151.66M |
| Total Debt | 0.0 | 21.85M | 14.13M | 72,000.0 | 0.0 |
| Cash & Equivalents | 257.84M | 273.74M | 99.70M | 142.14M | 133.54M |
| Current Assets | 419.32M | 281.62M | 103.87M | 146.06M | 137.22M |
| Current Liabilities | 66.70M | 38.85M | 32.25M | 17.89M | 10.41M |